Trial Profile
Efficacy and tolerability of levetiracetam in central post-stroke pain - a randomised, double blind, placebo controlled, cross-over study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Feb 2023
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Central pain; Neuropathic pain
- Focus Therapeutic Use
- Acronyms LESS
- 18 Sep 2009 New trial record.